Pages
800,000 people, 1.8 million jabs
One year of the Covid-19 vaccination programme in Derbyshire.
World Mental Health Day
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/world-mental-health-day
DCHS inclusion conference 2023
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/dchs-inclusion-conference-2023
October has been AAC Awareness Month
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/october-has-been-aac-awareness-month
Files
Post Registration Transition Programme for Newly Qualified Specialist Practice District Nurses Procedure (S53)
The aim of this document is to set out the processes that DCHS uses to support and develop Newly Qualified Specialist Practice District Nurses (NQDN) in their first year of employment. This is a process of support and guidance offered, on completion of the 1 year post reg. MSc/BSC SPQ during the first 12 months of employment as a band 6 Community Nursing caseload holder.
Person Centred Care Planning Guidance booklet (G51)
This aim of this booklet is to supply guidance on how to write person centred care plans
Standard Operating Procedure (SOP) for The T34 and Bodyguard Syringe Drivers (S61)
A subcutaneous infusion pump is an effective method of administering therapeutic drugs via subcutaneous route, which can no longer be tolerated orally or rectally by the patient. The aim of this SOP is to provide guidance for staff in the use of the McKinley T34 pump across adult services. Using a uniform SOP will reduce the level of risks associated with syringe pump management within DCHS.
Prevention and Management Pressure Ulcer Policy (P36)
This policy outlines the Trust’s approach for the prevention of pressure ulcers in people under the care of DCHS clinicians. It encompasses the appropriate management for the prevention of pressure ulcers as well as the management of patients with ulcers already present. This policy and the supporting guidelines place an emphasis on a collaborative integrated multidisciplinary, multiagency approach to identifying risk factors and the implementation of appropriate preventative and/or treatment measures in a timely manner.
Communications Annex V7.pdf
How to communicate with Patients using the communication annexe on SystmOne
Conservative Sharp Debridement (CSD) of Wounds Policy (P99)
We know that wound dressings should provide the optimal environment for wound healing after careful clinical assessment of the wound, the patient clinical condition and clinical outcomes. Hard to heal wounds, however, fail to progress, and many can be seen with dead tissue, slough and necrosis which in turn can increase the risk of infection and also increase cost within appropriate dressing use and nursing time. This procedure will only be undertaken by the Tissue Viability team members who have successfully completed a validated programme of care and assessment of competence in practice. A minimum of 10 episodes of observed practice is to be completed until competency can be granted. The purpose of debridement describes any method by which such materials (necrosis, slough and dead de-vascularised tissue) are removed and consequently the potential to achieve wound healing enhanced. It also reduces the bacterial load and minimises the risk of local and systemic infection. It can allow for wound draining and reduce odour overall enhancing patient quality of life.
Patient Experience Team leaflet
Patient experience team leaflet, includes information on how to make a complaint and where patients/carers can access support. Updated 2022
Disclosure Ref 2022124 - Staffing systems used.pdf
Response to FOI regarding Staffing systems used
Request for Temporary Electronic Prescribing Access for Agency Non-Medical Prescribers (A6 P57)
Request for Temporary Electronic Prescribing Access for Agency Non-Medical Prescribers For agency staff with a current and unrestricted independent NMP qualification who require temporary access to prescribing on SystmOne in order to maintain services. Requests must be authorised by both the service manager and DCHS Chief Pharmacist.
Disclosure Ref 2024176 - Spend on office supplies.pdf
FOI Disclosure Ref 2024176 relating to Spend on office supplies